External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: A multi-institutional analysis

ERDEM, Selçuk; Capitanio, Umberto; Campi, Riccardo; Mir, Maria; Roussel, Eduard; Pavan, Nicola; Kara, ÖNDER; Klatte, Tobias; Kriegmair, Maximilian; Degirmenci, Enes; Aydin, Resat; Minervini, Andrea; Serni, Sergio; Berni, Alessandro; Rebez, Giacomo; Ozcan, Faruk

doi:10.1016/j.urolonc.2022.01.006

External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: A multi-institutional analysis

Atıf İçin Kopyala

ERDEM S., Capitanio U., Campi R., Mir M. C., Roussel E., Pavan N., ...Daha Fazla

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, cilt.40, sa.5, 2022 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 40 Sayı: 5
Basım Tarihi: 2022
Doi Numarası: 10.1016/j.urolonc.2022.01.006
Dergi Adı: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
Anahtar Kelimeler: Disease recurrence after curative surgery, Non-metastatic, Papillary renal cell carcinoma, Validation, VENUSS Prognostic model, CLEAR-CELL, TYPE-1, NOMOGRAM, SURVIVAL, OUTCOMES, TRIAL
Kocaeli Üniversitesi Adresli: Hayır

Özet

Objective: Recently, VENUSS (VEnous extension, NUclear Grade, Size, Stage), as a prognostic model, was defined to predict disease recurrence (DR) after curative surgery of non-metastatic papillary renal cell carcinoma (papRCC). This study aimed to validate the VENUSS prognostic model in a large multi-institutional European cohort of patients with histopathologically proven papRCC after curative surgery for non-metastatic disease.